Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 13/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 13/20 | 0.50 |
| ▸ | APP | P05067 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ACLY | P53396 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7997880 | 0.87 | ESR1 (0.50) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL21814918 | 0.81 | MAPT (0.50) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL21226564 | 0.81 | KDM4E (0.72) | KDM4EMAPTNPC1RAB9AUSP2 | |
| SCHEMBL6598725 | 0.80 | ESR1 (0.44) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL17232968 | 0.80 | MAPT (0.56) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL9199893 | 0.79 | ESR1 (0.53) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL21815077 | 0.78 | MEN1 (0.56) | ESR1ESR2APPKDM4EMAPT | |
| SCHEMBL6595430 | 0.76 | ESR1 (0.55) | ESR1ESR2APPNPC1RAB9A | |
| SCHEMBL12050571 | 0.75 | RAB9A (0.66) | MAPTNPC1RAB9AUSP2SMN1; SMN2 | |
| SCHEMBL24095083 | 0.75 | ESR1 (0.45) | ESR1ESR2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1230227-B1 | BENZOXA-AND BENZOTHIAZOLYL SULFAMATES AND THEIR USE AS STEROID SULFATASE INHIBITORS | NOVARTIS AG (CH) | 2004-06-23 | — | — | EP | disclosed |
| US-6716865-B1 | SUBSTITUTED AT THE 2 POSITION; A SULFAMATE BOUND VIA OXYGEN TO THE PHENYL PART OF THE RING STRUCTURE; SULFAMOYLATION; STEROID SULFATASE INHIBITOR, ACNE | NOVARTIS AG (CH) | 2004-04-06 | — | — | US | disclosed |
| EP-1230227-A1 | BENZOXA-AND BENZOTHIAZOLYL SULFAMATES AND THEIR USE AS STEROID SULFATASE INHIBITORS | Novartis AG (CH) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001036398-A1 | BENZOXA- AND BENZTHIAZOLES | NOVARTIS AG (CH) | 2001-05-25 | — | — | WO | disclosed |